Miyata; Toshio
Patent Applications and Registrations
Patent applications and USPTO patent grants for Miyata; Toshio.The latest application filed is for "orally active small molecule inhibitor of pai-1".
Company Profile
4.29.31
- Miyata; Toshio - Tokyo JP
- Miyata; Toshio - Miyagi JP
- MIYATA; Toshio - Nagoya-shi Aichi
- Miyata; Toshio - Evanston IL
- Miyata; Toshio - Kanagawa JP
- Miyata; Toshio - Sendai N/A JP
- Miyata; Toshio - Isehara-shi JP
- Miyata; Toshio - Sendai-shi JP
- Miyata; Toshio - Isehara JP
Patent Activity
| Patent | Date |
|---|---|
| Orally Active Small Molecule Inhibitor Of Pai-1 App 20220143185 - Vaughan; Douglas E. ; et al. | 2022-05-12 |
| Composition used to improve symptoms of autism spectrum disorder, and method using same for improving symptoms of autism spectrum disorder Grant 11,253,519 - Miyata , et al. February 22, 2 | 2022-02-22 |
| Pharmaceutical Composition Formed By Combining Pyridoxamine Compound And Thiamine Compound App 20210000829 - MIYATA; Toshio | 2021-01-07 |
| Composition Used To Improve Symptoms Of Autism Spectrum Disorder, And Method Using Same For Improving Symptoms Of Autism Spectrum Disorder App 20200368233 - MIYATA; Toshio ; et al. | 2020-11-26 |
| Recombinant Microorganism And Method Of Producing Pyridoxamine Or Salt Thereof Using Recombinant Microorganism App 20200149079 - TATENO; Toshihiro ; et al. | 2020-05-14 |
| Recombinant Microorganism, Method Of Producing Pyridoxamine Or Salt Thereof Using Recombinant Microorganism, And Method Of Produ App 20200123581 - TATENO; Toshihiro ; et al. | 2020-04-23 |
| Methods And Compositions For Modulating Fgf23 Levels App 20200046811 - Vaughan; Douglas E. ; et al. | 2020-02-13 |
| Use for PAI-1 inhibitor Grant 10,092,537 - Ando , et al. October 9, 2 | 2018-10-09 |
| Pharmaceutical Composition Formed By Combining Pyridoxamine Compound And Thiamine Compound App 20170258791 - MIYATA; Toshio | 2017-09-14 |
| Novel Use For Pai-1 Inhibitor App 20160158188 - ANDO; Kiyoshi ; et al. | 2016-06-09 |
| Methods And Compositions For Modulating Fgf23 Levels App 20160144001 - Vaughan; Douglas E. ; et al. | 2016-05-26 |
| Detection And Treatment Of Schizophrenia App 20140335517 - ITOKAWA; Masanari ; et al. | 2014-11-13 |
| Plasminogen Activator Inhibitor-1 Inhibitor App 20140296256 - MIYATA; Toshio ; et al. | 2014-10-02 |
| Detection and treatment of schizophrenia Grant 8,809,329 - Itokawa , et al. August 19, 2 | 2014-08-19 |
| Plasminogen activator inhibitor-1 inhibitor Grant 8,785,473 - Miyata , et al. July 22, 2 | 2014-07-22 |
| Oral Medicinal Composition For Patients Undergoing Peritoneal Dialysis And Method For Using Same App 20130338574 - Kakuta; Takatoshi ; et al. | 2013-12-19 |
| Inhibitor of plasminogen activator inhibitor-1 Grant 8,415,479 - Miyata , et al. April 9, 2 | 2013-04-09 |
| Detection and Treatment of Schizophrenia App 20120065198 - ITOKAWA; Masanari ; et al. | 2012-03-15 |
| Plasminogen Activator Inhibitor-1 Inhibitor App 20120022080 - Miyata; Toshio ; et al. | 2012-01-26 |
| Plasminogen activator inhibitor-1 inhibitor Grant 7,951,806 - Miyata , et al. May 31, 2 | 2011-05-31 |
| Inhibitor Of Plasminogen Activator Inhibitor-1 App 20110112140 - Miyata; Toshio ; et al. | 2011-05-12 |
| Detection and Treatment of Schizophrenia App 20110028470 - Itokawa; Masanari ; et al. | 2011-02-03 |
| Peritoneum Protecting Agent App 20110021579 - MIYATA; Toshio ; et al. | 2011-01-27 |
| Method for preparing peritoneal dialysate Grant 7,745,613 - Miyata June 29, 2 | 2010-06-29 |
| Inhibitor of protein modification products formation Grant 7,645,882 - Miyata , et al. January 12, 2 | 2010-01-12 |
| Plasminogen Activator Inhibitor-1 Inhibitor App 20090124620 - Miyata; Toshio ; et al. | 2009-05-14 |
| Peritoneum Protecting Agent App 20090030047 - Miyata; Toshio ; et al. | 2009-01-29 |
| Megsin/Rage/Inos-Overexpressing Renal Disease Model Animals and Methods for Evaluating Compounds Using the Model Animals App 20080263683 - Miyata; Toshio ; et al. | 2008-10-23 |
| Phenylene derivative having tetrazole ring or thiazolidinedione ring Grant 7,417,052 - Yanagisawa , et al. August 26, 2 | 2008-08-26 |
| MEGSIN protein Grant 7,368,251 - Miyata May 6, 2 | 2008-05-06 |
| Method for preparing peritoneal dialysate Grant 7,297,689 - Miyata November 20, 2 | 2007-11-20 |
| Modified-protein formation inhibitor App 20070161691 - Miyata; Toshio ; et al. | 2007-07-12 |
| Inhibitor of protein modification products formation App 20070123577 - Miyata; Toshio ; et al. | 2007-05-31 |
| Phenylene derivative having tetrazole ring or thiazolidinedione ring App 20070105846 - Yanagisawa; Hiroaki ; et al. | 2007-05-10 |
| Carbonyl stress-decreasing agent Grant 7,169,407 - Miyata January 30, 2 | 2007-01-30 |
| Method For Preparing Peritoneal Dialysate App 20070020341 - Miyata; Toshio | 2007-01-25 |
| Carbonyl stress-ameliorating agents Grant 7,029,906 - Miyata April 18, 2 | 2006-04-18 |
| Method for detecting megsin protein and use thereof Grant 7,026,126 - Miyata April 11, 2 | 2006-04-11 |
| Meg-3 protein App 20060068437 - Miyata; Toshio | 2006-03-30 |
| Method for preparing peritoneal dialysate App 20050267045 - Miyata, Toshio | 2005-12-01 |
| Carbonyl-stress improving agent and peritoneal dialysate Grant 6,919,326 - Miyata July 19, 2 | 2005-07-19 |
| MEGSIN protein App 20050106628 - Miyata, Toshio | 2005-05-19 |
| Megsin promoter Grant 6,790,617 - Miyata September 14, 2 | 2004-09-14 |
| Meg-4 protein App 20040137495 - Miyata, Toshio | 2004-07-15 |
| Meg-4 protein Grant 6,680,370 - Miyata January 20, 2 | 2004-01-20 |
| Carbonyl stress-ameliorating agents App 20030143215 - Miyata, Toshio | 2003-07-31 |
| Impact sensor and manufacturing method therefor Grant 5,773,720 - Miyata June 30, 1 | 1998-06-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 